Search research articles
Contact Us
Filters
Showing results (41-50 of 43) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 43 results.
Experientia
|
June 15, 1977
Specific immunostaining of CCK cells by use of synthetic fragment antisera
J M Polak, A G Pearse, M Szelke, et al.
Journal of Medicinal Chemistry
|
January 31, 1997
(3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist
G Semple, H Ryder, D P Rooker, et al.
Biochemical Society Transactions
|
August 1, 1987
Inhibitors of aspartic proteinases and their relevance to the design of antihypertensive agents
J B Cooper, S I Foundling, A Hemmings, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 43) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 43 results.
Experientia
|
June 15, 1977
Specific immunostaining of CCK cells by use of synthetic fragment antisera
J M Polak, A G Pearse, M Szelke, et al.
Journal of Medicinal Chemistry
|
January 31, 1997
(3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist
G Semple, H Ryder, D P Rooker, et al.
Biochemical Society Transactions
|
August 1, 1987
Inhibitors of aspartic proteinases and their relevance to the design of antihypertensive agents
J B Cooper, S I Foundling, A Hemmings, et al.
Page
of 5